SEC Form 4 · accession 0001144204-16-077384
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Aug 5, 2015
Accepted (ET)
Jan 27, 2016 · 9:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2015 | A | 10,000 | $0.00 | A | 58,209 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer